GISSI-2: mortality plus extensive left-ventricular damage as "end-point".
De Vita C, Franzosi MG, Geraci E, Maggioni AP, Mauri F, Mezzanotte G, Tavazzi L, Tognoni G, Volpi A.
De Vita C, et al. Among authors: franzosi mg.
Lancet. 1990 Feb 3;335(8684):289. doi: 10.1016/0140-6736(90)90104-d.
Lancet. 1990.
PMID: 1967740
Clinical Trial.
No abstract available.